Pharma’s AI prospects get nudged into the future with EU’s AI act
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
Regulation
Are regulators keeping pace with AI adoption in clinical trials?
FDA plans to expand unannounced inspections of foreign drug plants
EU Health Data Space strikes a chord in EU harmonisation plans
European agencies catch up with speedier regulatory pathways for CGTs in the US
J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract
EU reshapes HTAs: is the industry ready for it?
Pfizer settles Biohaven kickback claims case for $59.7m
